Geba GP - Search Results

1

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.

Busse WW, Katial R, Gossage D, Sari S, Wang B, Kolbeck R, Coyle AJ, Koike M, Spitalny GL, Kiener PA, Geba GP, Molfino NA. Busse WW, et al. Among authors: geba gp. J Allergy Clin Immunol. 2010 Jun;125(6):1237-1244.e2. doi: 10.1016/j.jaci.2010.04.005. J Allergy Clin Immunol. 2010. PMID: 20513521 Clinical Trial.

2

Generic pills from the patient perspective: dressed for success?

Yu LX, Geba GP. Yu LX, et al. Among authors: geba gp. JAMA Intern Med. 2013 Feb 11;173(3):208-9. doi: 10.1001/jamainternmed.2013.2283. JAMA Intern Med. 2013. PMID: 23277345 No abstract available.

3

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.

Mohammadi KA, Brackin T, Schwartz GG, Steg PG, Szarek M, Manvelian G, Pordy R, Fazio S, Geba GP. Mohammadi KA, et al. Among authors: geba gp. Cancer Med. 2023 Aug;12(16):16859-16868. doi: 10.1002/cam4.6310. Epub 2023 Jul 17. Cancer Med. 2023. PMID: 37458138 Free PMC article.

4

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.

Busse WW, Massanari M, Kianifard F, Geba GP. Busse WW, et al. Among authors: geba gp. Curr Med Res Opin. 2007 Oct;23(10):2379-86. doi: 10.1185/030079907X226258. Curr Med Res Opin. 2007. PMID: 17711616 Clinical Trial.

5

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Massanari M, Nelson H, Casale T, Busse W, Kianifard F, Geba GP, Zeldin RK. Massanari M, et al. Among authors: geba gp. J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022. J Allergy Clin Immunol. 2010. PMID: 20159249 Clinical Trial.

6

Brain magnetic resonance imaging in adults with asthma.

Parker J, Wolansky LJ, Khatry D, Geba GP, Molfino NA. Parker J, et al. Among authors: geba gp. Contemp Clin Trials. 2011 Jan;32(1):86-9. doi: 10.1016/j.cct.2010.09.006. Epub 2010 Sep 18. Contemp Clin Trials. 2011. PMID: 20854931

7

Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma.

Oh CK, Geba GP, Molfino N. Oh CK, et al. Among authors: geba gp. Eur Respir Rev. 2010 Mar;19(115):46-54. doi: 10.1183/09059180.00007609. Eur Respir Rev. 2010. PMID: 20956165 Free PMC article. Review.

8

Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma.

Oh CK, Raible D, Geba GP, Molfino NA. Oh CK, et al. Among authors: geba gp. Inflamm Allergy Drug Targets. 2011 Jun;10(3):180-6. doi: 10.2174/187152811795564073. Inflamm Allergy Drug Targets. 2011. PMID: 21428906 Review.

9

Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.

Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP. Molfino NA, et al. Among authors: geba gp. Clin Exp Allergy. 2012 May;42(5):712-37. doi: 10.1111/j.1365-2222.2011.03854.x. Epub 2011 Sep 23. Clin Exp Allergy. 2012. PMID: 22092535 Review.

10

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.

Piper E, Brightling C, Niven R, Oh C, Faggioni R, Poon K, She D, Kell C, May RD, Geba GP, Molfino NA. Piper E, et al. Among authors: geba gp. Eur Respir J. 2013 Feb;41(2):330-8. doi: 10.1183/09031936.00223411. Epub 2012 Jun 27. Eur Respir J. 2013. PMID: 22743678 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters